Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 2/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.42 |
| ▸ | RAF1 | P04049 | 2/20 | 0.40 |
| ▸ | MAP2K1 | Q02750 | 2/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.40 |
| ▸ | HTR2A | P28223 | 1/20 | 0.40 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.40 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | AR | P10275 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL669346 | 0.93 | SMN1; SMN2 (0.57) | POLBGAASMN1; SMN2KDM4EMAPT | |
| Ammonia Solution, Strong SCHEMBL28193306 | 0.92 | SMN1; SMN2 (0.56) | POLBGAASMN1; SMN2KDM4EMAPT | |
| SCHEMBL9745478 | 0.90 | SMN1; SMN2 (0.58) | POLBGAASMN1; SMN2KDM4EMAPT | |
| SCHEMBL9746326 | 0.90 | SMN1; SMN2 (0.54) | POLBGAASMN1; SMN2KDM4EMAPT | |
| SCHEMBL9745662 | 0.90 | SMN1; SMN2 (0.58) | POLBGAASMN1; SMN2KDM4EMAPT | |
| SCHEMBL9746110 | 0.87 | SMN1; SMN2 (0.52) | POLBGAASMN1; SMN2KDM4EMAPT | |
| SCHEMBL9746273 | 0.86 | SMN1; SMN2 (0.54) | POLBGAASMN1; SMN2KDM4EMAPT | |
| SCHEMBL21352429 | 0.83 | SMN1; SMN2 (0.50) | POLBGAASMN1; SMN2KDM4EMAPT | |
| SCHEMBL8975487 | 0.82 | POLB (0.73) | POLBGAASMN1; SMN2KDM4EMAPT | |
| SCHEMBL17090701 | 0.81 | MAPT (0.47) | POLBGAASMN1; SMN2KDM4EMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8242262-B2 | Process for preparing chlorides of phthalocyanine derivatives comprising at least a quaternary ammonium group | L. MOLTENI & C. DEI FRATELLI ALITTI SOCIETA'DI ESERCIZIO S.P.A. (IT) | 2012-08-14 | — | — | US | disclosed |
| US-8067404-B2 | Phthalocyanine derivatives, process for their preparation, pharmaceutical compositions containing them and their use | L. MOLTENI & C. DEI FRATELLI ALITTI SOCIETA'DI ESERCIZIO S.P.A. (IT) | 2011-11-29 | — | — | US | disclosed |
| EP-1883640-B1 | PROCESS FOR PREPARING CHLORIDES OF PHTHALOCYANINE DERIVATIVES COMPRISING AT LEAST A QUATERNARY AMMONIUM GROUP | MOLTENI & C (IT) | 2009-08-26 | — | — | EP | disclosed |
| US-20090131393-A1 | Process for Preparing Chlorides of Phthalocyanine Derivatives Comprising at Least a Quaternary Ammonium Group | L. MOLTENI & C. DEI FRATELLI ALITTI SOCIETA' DI ESERCIZIO S.P.A. (IT) | 2009-05-21 | — | — | US | disclosed |
| US-20090131392-A1 | PHTALOCYANINE DERIVATIVES, PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE | L. MOLTENI & C. DEI FRATELLI ALITTI SOCIETA' DI ESERCIZIO S.P.A. (IT) | 2009-05-21 | — | — | US | disclosed |
| EP-1883641-B1 | PHTHALOCYANINE DERIVATIVES, PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE | MOLTENI & C (IT) | 2008-11-26 | — | — | EP | disclosed |
| EP-1883640-A2 | PROCESS FOR PREPARING CHLORIDES OF PHTHALOCYANINE DERIVATIVES COMPRISING AT LEAST A QUATERNARY AMMONIUM GROUP | L. MOLTENI & C. DEI FRATELLI ALITTI SOCIETA' DI ESERCIZIO SOCIETA' PER AZIONI (IT) | 2008-02-06 | — | — | EP | disclosed |
| EP-1883641-A1 | PHTHALOCYANINE DERIVATIVES, PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE | L. MOLTENI & C. DEI FRATELLI ALITTI SOCIETA' DI ESERCIZIO S.P.A (IT) | 2008-02-06 | — | — | EP | disclosed |
| WO-2006117399-A1 | PHTHALOCYANINE DERIVATIVES, PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE | L. MOLTENI & C. DEI FRATELLI ALITTI - SOCIETA' DI ESERCIZIO S.P.A. (IT) | 2006-11-09 | — | — | WO | disclosed |
| WO-2006117396-A2 | PROCESS FOR PREPARING CHLORIDES OF PHTHALOCYANINE DERIVATIVES COMPRISING AT LEAST A QUATERNARY AMMONIUM GROUP | L. MOLTENI & C. DEI FRATELLI ALITTI SOCIETA' DI ESERCIZIO S.P.A. (IT) | 2006-11-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090131392-A1 | PHTALOCYANINE DERIVATIVES, PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE | PHLPP1, PHLPP2, PHYKPL | POLB 988/4885GAA 616/4885SMN1; SMN2 3753/4885 |
| US-20090131393-A1 | Process for Preparing Chlorides of Phthalocyanine Derivatives Comprising at Least a Quaternary Ammonium Group | PHLPP1, PHPT1, PHLPP2 | POLB 1188/4885GAA 693/4885SMN1; SMN2 3950/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.